- Home
- CREG vs TCBP Comparison
CREG vs TCBP Comparison
Compare CREG & TCBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CREG
- TCBP
- Stock Information
- Founded
- CREG 1980
- TCBP 2013
- Country
- CREG China
- TCBP United Kingdom
- Employees
- CREG N/A
- TCBP N/A
- Industry
- CREG Power Generation
- TCBP Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CREG Utilities
- TCBP Health Care
- Exchange
- CREG Nasdaq
- TCBP Nasdaq
- Market Cap
- CREG 6.0M
- TCBP 5.0M
- IPO Year
- CREG N/A
- TCBP 2022
- Fundamental
- Price
- CREG $0.63
- TCBP $0.38
- Analyst Decision
- CREG
- TCBP Strong Buy
- Analyst Count
- CREG 0
- TCBP 1
- Target Price
- CREG N/A
- TCBP $2.40
- AVG Volume (30 Days)
- CREG 88.2K
- TCBP 3.1M
- Earning Date
- CREG 11-08-2024
- TCBP 11-25-2024
- Dividend Yield
- CREG N/A
- TCBP N/A
- EPS Growth
- CREG N/A
- TCBP N/A
- EPS
- CREG N/A
- TCBP N/A
- Revenue
- CREG N/A
- TCBP N/A
- Revenue This Year
- CREG N/A
- TCBP N/A
- Revenue Next Year
- CREG N/A
- TCBP N/A
- P/E Ratio
- CREG N/A
- TCBP N/A
- Revenue Growth
- CREG N/A
- TCBP N/A
- 52 Week Low
- CREG $0.53
- TCBP $0.37
- 52 Week High
- CREG $2.00
- TCBP $32.70
- Technical
- Relative Strength Index (RSI)
- CREG 43.06
- TCBP 30.77
- Support Level
- CREG $0.53
- TCBP $0.37
- Resistance Level
- CREG $0.67
- TCBP $0.47
- Average True Range (ATR)
- CREG 0.09
- TCBP 0.10
- MACD
- CREG -0.01
- TCBP 0.01
- Stochastic Oscillator
- CREG 28.14
- TCBP 2.65
About CREG Smart Powerr Corp.
Smart Powerr Corp is a pioneer in waste energy recycling and a developer of energy efficiency solutions for various energy-intensive industries in China. It uses the Build-Operate-Transfer (BOT) model to provide energy-saving and recovery facilities for multiple energy-intensive industries in China. Its waste energy recycling projects allow customers which use substantial amounts of electricity to recapture previously wasted pressure, heat, and gas from their manufacturing processes to generate electricity. The company currently offer waste energy recycling systems to companies for use in nonferrous metal plants. It constructs its projects at its customer's facility and the electricity produced is used on-site by the customer.
About TCBP TC BioPharm (Holdings) plc
TC BioPharm (Holdings) PLC is a clinical-stage biopharmaceutical company focused on developing novel immunotherapy products that are based on its proprietary allogeneic gamma delta T (abbreviated as GD-T) cell platform. Harnessing the innate ability of GD-Ts has enabled the company to develop a range of clinical-stage cell therapies designed to combat cancer and viral infection.